GlassScriptPhysician profile
Noah T Scherrer
NPI 1740423896
$7,599.20
in general payments reported to CMS, 2019-2025
28 companies · $1,135 in 2025
The $1,135 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $345 · 2020: $378 · 2021: $448 · 2022: $2,907 · 2023: $358 · 2024: $2,028 · 2025: $1,135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,893 · Travel and Lodging: $1,628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,892.60 |
| Travel and Lodging | $1,628.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $5,014.19 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo, Gore Tag Thoracic Branch Endoprosthesis |
| Boston Scientific Corporation | $959.85 | 2019-2025 | Eluvia, General - Thrombectomy, General - Atherectomy |
| Terumo Medical Corporation | $240.06 | 2019-2020 | |
| Sanara Medtech INC. | $197.89 | 2022-2025 | Celleraterx, Celleraterx |
| Endologix LLC | $170.54 | 2024 | Endocross Device, Torus Stent Graft System |
| Bolton Medical INC | $154.78 | 2025 | Treo Abdominal Stent-Graft System |
| Silk Road Medical, INC. | $130.74 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Lemaitre Vascular, INC. | $102.80 | 2019 | |
| Bone Support INC. | $89.11 | 2024-2025 | Ceramentbone Void Filler, Cerament G |
| Inari Medical, INC. | $80.84 | 2022 | |
| Medtronic USA, INC. | $74.42 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $53.02 | 2020-2021 | |
| Stryker Corporation | $43.74 | 2025 | Artix Mt, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cook Medical LLC | $32.37 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $31.77 | 2025 | Lutonix Drug Coated Balloon |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ekos Corporation | $27.08 | 2019 | |
| Baxter Healthcare | $25.83 | 2022 | |
| Angiodynamics, INC. | $23.95 | 2020 | |
| Medtronic, INC. | $17.84 | 2021 | |
| Pfizer INC. | $17.35 | 2022 | |
| Atricure, INC. | $16.33 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Argon Medical Devices, INC. | $15.73 | 2025 | Clot Management |
| Polynovo North America LLC | $14.19 | 2024 | Novosorb Btm |
| Smith+Nephew, INC. | $14.16 | 2025 | Iodosorb Ointment 40g USA, Collagenase Santyl |
| Pacira Pharmaceuticals Incorporated | $13.65 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.31 | 2022 | |
| Surmodics, INC. | $11.98 | 2025 | Pounce Venous Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight, Pounce Thrombectomy System |
| Philips North America LLC | $11.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noah Scherrer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.